Thursday, 3 October 2013

New hope for treating antibiotic resistant bacteria


Parliamentary Yearbook examines new research which suggests that adding silver to antibiotics makes them one thousand times more effective at fighting infections.  It is hoped that the findings could help in the fight against antibiotic resistance.

Silver has been used as an antimicrobial for centuries. Despite this widespread use, the exact mechanism of its action has remained unclear. New research by a team of American scientists has been published in the journal Translational Medicine which identifies exactly how silver fights bacteria in a number of ways.  The research suggests that adding silver to existing anitbiotics could help strengthen the antibiotic arsenal for fighting bacterial infections.

Silver has been used to fight infections for thousands of years.   Hippocrates first described its antimicrobial properties in 400 b.c.; noting its special ability to preserve food and water. Today silver is routinely used to treat and prevent infections and can be found in wound dressings and catheters but the source of this precious metal’s antibacterial properties has remained a mystery.  In this latest research, James Collins, of the Wyss Institute for Biologically Inspired Engineering at Harvard University and colleagues from Boston University, describe a number of ways in which silver fights bacteria.   

The study is important because it investigates the effects of silver on E.coli, a Gram-negative bacterium. The most difficult types of infections to are those that involve Gram-negative bacteria, like E.coli and Salmonella.  These bacterial strains have an almost impenetrable cell wall that shields them from antibiotics.  They are resistant to multiple drugs and are increasingly resistant to most available antibiotics.  Gram-negative bacteria have built-in abilities to find new ways to be resistant and can pass along genetic materials that allow other bacteria to become drug-resistant as well. 

The research team conducted a series of experiments using E.coli in petri dishes and in live mice suffering from urinary tract infections.  The study aimed to investigate exactly how silver kills Gram-negative bacteria. 

The findings show that silver mounts a multi-targeted attack on the bacteria which breaks down their cells walls and increases their production of reactive oxygen species (ROS), chemically reactive molecules containing oxygen.  An increase in ROS molecules, caused by traditional antibiotics or silver automatically triggers bacterial cell death.

The researchers subsequently investigated the effects of combining silver with a range of antibiotics. They found that the silver acted as a sort of Trojan horse.  It helped to deliver the treatment beyond the cells’ walls which allowed the antibiotic to maximally damage the bacterial cells. 

The findings were remarkable.  They showed that antibiotics, when combined with silver, were 10 to 1,000 times more effective at fighting infections than when antibiotics alone were used. Even at small doses, silver made the E.coli up to one thousand times more sensitive to gentamycin, ofloxacin and ampicillin; three widely used antibiotics.

In further tests with mice, they found that a E.coli urinary tract infection that was resistant to tetracycline finally succumbed when the antibiotic was combined with silver.  Similarly, they found that, combined with silver, vancomyin saved the lives of 90% of mice with life-threatening peritonitis. Treated with vancomycin alone, 90% of the mice died.

The doses of silver used used in the experiments were tested to ensure they were not toxic.  The team showed that levels were too low to harm the mice. It was also confirmed that levels used did not harm human cells.

The researchers believe that silver may enable existing antibiotics to treat a wider range of infections, including those to which microbes have become resistant.

Commenting on the research, Jim Collins said:  “We’re keen to explore how smart drug-delivery nanotechnologies being developed at the Wyss could help deliver effective but nontoxic levels of silver to sites of infection.”

Email: parliamentaryyearbook@blakemedia.org


New research offers hope for new treatments for multiple sclerosis


Parliamentary Yearbook reports on the new research led by scientists at the University of Edinburgh and the University of Cambridge which may help to develop a treatment to repair nerve damage in multiple sclerosis. The research identifies the important role of immune cells, called macrophages, in the regeneration of the myelin sheath.

Nerve cells have extremely long thin nerve fibres which transmit impulses between distant parts of the body, enabling normal body function. A fatty layer called the myelin sheath insulates each nerve fibre in the brain and spinal cord.  This protective layer speeds up the transmission of electrical impulses as they pass along nerve fibres to and from the brain.  At certain intervals, the myelin layer is interrupted creating what is called “a node of Ranvier”.  These nodes in the myelin sheath have a vital function in speeding up the transmission of signals or impulses to and from the brain.  Rather than travelling the entire length of nerve fibres, electrical impulses travel from node to node. This enables nerve fibres to conduct signals at tremendous speeds in excess of 100 metres per second.

If the myelin sheath is inflamed, damaged or destroyed, nerve fibres are unable to transmit impulses efficiently. The transmission of impulses gets slower - as the impulse has no alternative but to travel the entire length of the nerve fibre - or stops.  In MS, the immune system attacks the myelin sheath causing it to becomes damaged.  At the same time, a natural process (called remyelination) in which cells called ‘oligodendrocytes’ repair myelin damage gradually fails.  Consequently, the transmission of nerve signals becomes disrupted in the way described which in turn causes impairment in sensation, movement, cognition or other functions depending on which nerves are involved. 

Currently, there are few treatments to suppress the immune system from causing further damage and no treatments which can repair the damage done.

Driven by the lack of therapies for progressive MS, the MS Society in the UK, the Wellcome Trust and the MS of Canada has funded this latest research.  Led by the University of Edinburgh and the University of Cambridge, the research investigated the regenerative process of remyelination in samples of brain tissue from humans with MS and in mice.

The researchers studied immune cells - called macrophages - known to be involved in remyelination.  They found that macrophages were found at higher levels when myelin regeneration was working well.  In addition, they identified that these important immune cells played a vital role in triggering remyelination. The macrophages released a protein called activin-A which stimulated oligdendrocytes to make myelin.

The study’s results suggest that studying macrophages and activin-A might lead to the development of regenerative therapies for multiple sclerosis.  Further research is planned which looks at how activin-A can be released artificially and whether its effects can be enhanced.

 A statement by the first author, Dr Veron Miron, from the Medical Council Centre for Regenrative Medicine at the University of Edinburgh, said:  “Approved therapies for multiple sclerosis work by reducing the initial myelin injury - they do not promote myelin regeneration. This study could help find new drugs to enhance myelin regeneration and help to restore lost functions in patients with multiple sclerosis.”

Email: parliamentaryyearbook@blakemedia.org


Wednesday, 2 October 2013

Diabetics denied access to prescriptions for vital blood testing strips


Parliamentary Yearbook reports on a survey by the charity Diabetes UK. The findings reveal alarming facts about the difficulties experienced by people with diabetes in accessing blood testing strips within the NHS. The charity warns of serious long-term health complications and consequent increased costs for the NHS.

Diabetes cannot be cured but can be controlled through diet and medication.  Treatment aims to keep blood glucose to normal levels in order to control symptoms and to minimise associated health problems. Monitoring and controlling blood sugar levels is vital because left untreated the condition can cause very serious complications which are difficult and expensive to treat.  Even a mildly raised blood glucose level that does not present any immediate symptoms can have damaging effects on blood vessels, nerves and organs in the longer term. Complications are frequently dramatic and include limb amputation, blindness, kidney failure, heart disease and stroke.

Effective treatment therefore relies crucially on regular measurement of blood glucose levels to establish that levels are within normal limits.  This is particularly important for people with Type 1 diabetes and those with insulin treated Type 2 diabetes. Measurement allows the diabetes patient to safely perform everyday activities that most people take for granted. For example, people with Type 1 diabetes need to test their blood every time they eat, more frequently if they exercise, and every time they drive. According to the charity Diabetes UK, a person with Type 1 diabetes typically self-tests blood at least four times a day. 

Diabetics rely on blood glucose testing strips - currently prescribed by the NHS - in order to test blood glucose levels. However, a new survey by Diabetes UK has revealed some alarming facts about the difficulties experienced by diabetics in getting access to blood glucose testing strips in the NHS. The results are summarized below.

Difficulty accessing blood test strips:

·      Out of 2,203 respondents, 39% had either been refused a prescription of blood glucose test strips or had their prescription restricted.
·     Of these, 55% had test strips restricted within the last year with 33% experiencing a prescription being refused or restricted in the last 6 months.
·      Of those experiencing restrictions, over half had Type 1 diabetes (or were carers of people with Type 1)

Reasons given for refusal or restricted access:

·    Of those who said their prescriptions had been restricted, nearly a quarter (24%) had been told by their GP that this was because of restrictions put in place by their local Clinical Commissioning Group (CCG), NHS boards or local health board guidelines
·       34% due to “cost saving measures”
·       30% told they were testing too much
·       19% were given no reason

Commenting on the findings, Barbara Young, Diabetes UK Chief Executive, said: “Test strips are the most basic tools for managing Type 1 diabetes ad insulin treated Type 2 diabetes so it is very worrying that so many people are telling us they are having their test strips rationed because of cost saving measures.”

The survey revealed widespread variation - in different parts of the country – in guidance on prescriptions, with some patients only receiving 2 strips per day. 

Ms Young described some of the reported impacts of these restrictions: “Our survey showed a lack of test strips was stopping them driving, exercising or knowing how much insulin to take when they are eating or whether they are experiencing a ‘hypo’ (hypoglycaemic episode) which needs to be treated immediately.”

As a result of their findings – which many will find scandalous - Diabetes UK is calling on health leaders to remove all blanket policies restricting the number of test strips being prescribed.  The charity has called for “the focus to be on supporting clinicians on how to approach individual assessment and review to reduce waste and meet individual needs”.

The charity has warned that rationing will put people’s lives at risk and, more importantly for government, will store up costs for the NHS in the future.  This is because diabetic complications - related to poorly monitored and controlled blood glucose - are extremely expensive to treat.

According to the charity’s Chief Executive: “Rationing test strips to save money does not make any sense, because it’s putting people at risk of complications that are hugely expensive to treat.”

Email: parliamentaryyearbook@blakemedia.org

Tuesday, 1 October 2013

Access to water, sanitation, and hygiene linked to height increase in young children


Parliamentary Yearbook reports on evidence from studies of children across several countries which suggests that access to water, sanitation and hygiene may boost growth in young children under the age of five years. The Cochrane Review identifies a height increase of 0.5cm.

The Cochrane Collaboration is an international network of over 31,000 people from over 120 countries who work together to help healthcare practitioners, policy makers, patients, their advocates and carers, make well-formed decisions about health care. It believes that global healthcare decision-making should be informed by high-quality, timely research evidence.  This independent and democratic organisation produces and disseminates evidence across all areas of health care. To this end, it has prepared over 5,000 formal reviews - known as the Cochrane Reviews - which have been published online in the Cochrane Database of Systematic Reviews. The reviews form part of The Cochrane Library. 

The London School of Hygiene and Tropical Medicine (LSHTM) and the international charity Wateraid have recently jointly carried out and authored a study for the Cochrane Review. The study examined how water, sanitation and hygiene - so called WASH interventions - impact on nutrition outcomes for children.

The background to the review - led by Dr Alan D Dangour, a public heath nutritionist from the LSHTM, states that 165 million children under the age of five years suffer from chronic undernutrition causing them to be short in height and 52 million suffer from acute undernutrition causing them to be very thin. This is important because poor growth in early life is known to increase the risks of illness and death in childhood.  The immediate causes of childhood undernutrition are cited as being inadequate dietary intake and infectious diseases such as diarrhoea. 

The aim of the review was to evaluate the effect of water, sanitation and hygiene on nutrition outcomes for children. This was done by compiling data WASH interventions and nutrition outcomes on nearly 10,000 children from studies of 14 countries. Data was collected from studies on low and middle-income countries where clean water and soap was not accessible relative to more developed countries.  This included Bangladesh, Ethiopia, Nigeria, Chile, Guatemala, Pakistan, Nepal, South Africa, Kenya and Cambodia.

The researchers found evidence that good sanitation resulted in a small increase (0.5cm) in height of children under five.  The authors believe that access to clean water and soap is likely to have led to the increase in height because of the reduction in microbiological and parasitic infestations in early childhood, which are know to negatively impact on growth.

The research was funded by the Department for International Development (DFID). According to the LSTMH website, Professor Tim Wheeler, Deputy Chief Scientific Adviser to the DFID, said:  “Failure to get the right nutrition in childhood can cause lifelong damage that cannot be undone.  This report provides further support to the idea that using clean water and soap remains one of the best ways to prevent contracting diarrhoea and stopping young children losing the essential nutrients vital for them to grow.”

Email: parliamentaryyearbook@blakemedia.org